Certolizumab pegol-induced palmoplantar pustulosis: A case report and review of the literature
Reumatol Clin (Engl Ed). 2019 Nov-Dec;15(6):e163-e165.
doi: 10.1016/j.reuma.2017.12.004.
Epub 2018 Jan 19.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, España. Electronic address: lurdesvs@hotmail.com.
- 2 Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, España.
No abstract available
Publication types
-
Case Reports
-
Letter
-
Review
MeSH terms
-
Arthritis, Rheumatoid / drug therapy
-
Certolizumab Pegol / adverse effects*
-
Foot Dermatoses
-
Hand Dermatoses / chemically induced*
-
Humans
-
Immunosuppressive Agents / adverse effects*
-
Male
-
Middle Aged
-
Psoriasis / chemically induced*
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Immunosuppressive Agents
-
Tumor Necrosis Factor-alpha
-
Certolizumab Pegol